BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 16, 2004
 |  BioCentury  |  Product Development

Psoriasis P.S.

Psoriasis P.S.

Product Dose PASI 50 PASI 75 PASI 90 PGA response
Amevive Biogen Idec Status: Mkt Trial C99-711
Placebo (186) 10% 4% NA 4%
7.5 mg IV weekly (367) 38% 14% NA 11%
p<0.001 p<0.001 p=0.004
Trial C99-712
Placebo (168) 18%...

Read the full 341 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >